Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Altered monocyte phenotype and dysregulated innate cytokine responses among people living with HIV and opioid-use disorder.

Underwood ML, Nguyen T, Uebelhoer LS, Kunkel LE, Korthuis PT, Lancioni CL.

AIDS. 2019 Nov 4. doi: 10.1097/QAD.0000000000002416. [Epub ahead of print]

PMID:
31687981
2.

The effect of interrupted anti-retroviral treatment on the reconstitution of memory and naive T cells during tuberculosis treatment in HIV patients with active pulmonary tuberculosis.

Nalukwago S, Lancioni CL, Oketcho JB, Canaday DHE, Boom WH, Ojok L, Mayanja-Kizza H.

Afr Health Sci. 2017 Dec;17(4):954-962. doi: 10.4314/ahs.v17i4.2.

3.

CD4+ T Cell Activation During the Newborn Period: Barriers Against and Pathways Toward Th1 Immunity.

Uebelhoer LS, Lancioni CL.

Crit Rev Immunol. 2018;38(1):1-15. doi: 10.1615/CritRevImmunol.2018025016. Review.

PMID:
29717661
4.

Resistance and Susceptibility to Mycobacterium tuberculosis Infection and Disease in Tuberculosis Households in Kampala, Uganda.

Stein CM, Zalwango S, Malone LL, Thiel B, Mupere E, Nsereko M, Okware B, Kisingo H, Lancioni CL, Bark CM, Whalen CC, Joloba ML, Boom WH, Mayanja-Kizza H.

Am J Epidemiol. 2018 Jul 1;187(7):1477-1489. doi: 10.1093/aje/kwx380.

5.

Direct TLR-2 Costimulation Unmasks the Proinflammatory Potential of Neonatal CD4+ T Cells.

Sinnott BD, Park B, Boer MC, Lewinsohn DA, Lancioni CL.

J Immunol. 2016 Jul 1;197(1):68-77. doi: 10.4049/jimmunol.1501297. Epub 2016 May 18.

6.

Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.

Johnson DF, Malone LL, Zalwango S, Mukisa Oketcho J, Chervenak KA, Thiel B, Mayanja-Kizza H, Stein CM, Boom WH, Lancioni CL; Tuberculosis Research Unit.

PLoS One. 2014 May 5;9(5):e96613. doi: 10.1371/journal.pone.0096613. eCollection 2014.

7.

TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosis.

Reba SM, Li Q, Onwuzulike S, Ding X, Karim AF, Hernandez Y, Fulton SA, Harding CV, Lancioni CL, Nagy N, Rodriguez ME, Wearsch PA, Rojas RE.

Eur J Immunol. 2014 May;44(5):1410-21. doi: 10.1002/eji.201344100. Epub 2014 Mar 14.

8.

Rv2468c, a novel Mycobacterium tuberculosis protein that costimulates human CD4+ T cells through VLA-5.

Li Q, Ding X, Thomas JJ, Harding CV, Pecora ND, Ziady AG, Shank S, Boom WH, Lancioni CL, Rojas RE.

J Leukoc Biol. 2012 Feb;91(2):311-20. doi: 10.1189/jlb.0711364. Epub 2011 Dec 7.

9.

Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3.

Lancioni CL, Mahan CS, Johnson DF, Walusimbi M, Chervenak KA, Nalukwago S, Charlebois E, Havlir D, Mayanja-Kizza H, Whalen CC, Boom WH.

J Infect Dis. 2011 Apr 1;203(7):992-1001. doi: 10.1093/infdis/jiq141.

10.

Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.

Lancioni CL, Li Q, Thomas JJ, Ding X, Thiel B, Drage MG, Pecora ND, Ziady AG, Shank S, Harding CV, Boom WH, Rojas RE.

Infect Immun. 2011 Feb;79(2):663-73. doi: 10.1128/IAI.00806-10. Epub 2010 Nov 15.

11.

Activation requirements and responses to TLR ligands in human CD4+ T cells: comparison of two T cell isolation techniques.

Lancioni CL, Thomas JJ, Rojas RE.

J Immunol Methods. 2009 May 15;344(1):15-25. doi: 10.1016/j.jim.2009.02.005. Epub 2009 Mar 9.

Supplemental Content

Loading ...
Support Center